MiniMed 780G System Use in Type 1 Diabetes During Ramadan Intermittent Fasting: A Systematic Literature Review and Expert Recommendations.

Autor:	Elbarbary N; Diabetes and Endocrinology Unit, Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Alguwaihes A; Division of Endocrinology, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.; Diabetes Center, Dallah Hospital, Riyadh, Saudi Arabia., Zarif H; Endocrinology section, Department of Medicine, King Abdulaziz Medical City, King Abdullah International Medical Research Centre, Ministry of National Guards Health Affairs, Jeddah, Saudi Arabia.; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia., Hassanein M; Endocrine Department, Dubai Hospital, Dubai Academic Health Cooperation, Dubai, United Arab Emirates.; College of Medicine, Mohamed Bin Rashid University, Dubai, United Arab Emirates., Deeb A; Paediatric Endocrinology Division, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.; College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, United Arab Emirates., Petrovski G; Division of Endocrinology, Department of Pediatric Medicine, Sidra Medicine, Doha, Qatar.; College of Medicine, Weill Cornell Medicine, Doha, Qatar., Al Dahash R; Department of medicine, king Abdulaziz medical city-National Guard health Affairs, Riyadh, Saudi Arabia.; Department of medicine, King Saud Bin Abdulaziz for Health Science University, Riyadh, Saudi Arabia., Alamoudi R; Department of Medicine, King Abdulaziz Medical City, King Abdullah International Research Centre, Ministry of National Guards Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia., Hussain S; Department of Diabetes and Endocrinology, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.; Department of Diabetes, School of Cardiovascular, Metabolic Medicine and Sciences, King's College London, London, United Kingdom.; Institute of Diabetes, Endocrinology and Obesity, King's Health Partners, London, United Kingdom., Ibrahim M; EDC Center for Diabetes Education, Charlotte, North Carolina, USA., Shaikh S; Department of Diabetology & Endocrinology, Saifee Hospital, Mumbai, India., Zainudin SB; Department of Endocrinology, Department of General Medicine, Sengkang General Hospital, Singapore, Singapore., Chaar W; Clinical Research and Medical Science, Medtronic Saudi Arabia, Riyadh, Saudi Arabia., van den Heuvel T; Diabetes Operating Unit, Medtronic International Trading Sarl, Tolochenaz, Switzerland., Al-Sofiani ME; Division of Endocrinology, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.; Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University, Baltimore, Maryland, USA.
Jazyk:	angličtina
Zdroj:	Diabetes technology & therapeutics [Diabetes Technol Ther] 2024 Aug 22. Date of Electronic Publication: 2024 Aug 22.
DOI:	10.1089/dia.2024.0200
Abstrakt:	This article offers a systematic literature review (SLR) on the use of the MiniMed 780G automated insulin delivery system (MM780G) in people with type 1 diabetes (PwT1D) during Ramadan intermittent fasting. It also presents consensus recommendations on the use of MM780G during the Ramadan period. The SLR was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses methodology. The recommendations resulted from a consensus-forming process involving a panel of experts. The process considered evidence found in the SLR as well as the expert opinions. In total, six studies were included in the SLR. The evidence and expert opinions led to recommendations related to (a) pre-Ramadan counseling of MM780G users who plan to fast; (b) suggested MM780G settings, meal announcement strategy, and safety aspects during Ramadan (including a contingency plan); and (c) post-Ramadan transition into and out of Eid-al-Fitr festivities. The SLR findings showed that the MM780G maintains glycemic control at target in PwT1D during Ramadan (meeting continuous glucose monitoring-based clinical targets proposed by the International Consensus on Time-in-Range) while ensuring low rates of hypoglycemia and diabetic ketoacidosis. Automated insulin delivery also helps PwT1D fast more days of Ramadan compared with users of other less advanced modalities of treatment. Pre-Ramadan guidance on specific aspects of the MM780G along with the International Diabetes Federation and Diabetes and Ramadan International Alliance counseling guidelines is recommended. There is still a challenge with post-Iftar hyperglycemia, which could potentially be mitigated by following the recommendations outlined in this article.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu